Cargando…

Uncoupling of Proliferation and Cytokines From Suppression Within the CD4+CD25+Foxp3+ T–Cell Compartment in the 1st Year of Human Type 1 Diabetes

OBJECTIVE: The mechanistic basis for the breakdown of T-cell tolerance in type 1 diabetes is unclear and could result from a gain of effector function and/or loss of regulatory function. In humans, the CD4+CD25+Foxp3+ T–cell compartment contains both effector and regulatory T cells, and it is not kn...

Descripción completa

Detalles Bibliográficos
Autores principales: Hughson, Angela, Bromberg, Irina, Johnson, Barbara, Quataert, Sally, Jospe, Nicholas, Fowell, Deborah J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3142074/
https://www.ncbi.nlm.nih.gov/pubmed/21715555
http://dx.doi.org/10.2337/db10-1661
_version_ 1782208789202599936
author Hughson, Angela
Bromberg, Irina
Johnson, Barbara
Quataert, Sally
Jospe, Nicholas
Fowell, Deborah J.
author_facet Hughson, Angela
Bromberg, Irina
Johnson, Barbara
Quataert, Sally
Jospe, Nicholas
Fowell, Deborah J.
author_sort Hughson, Angela
collection PubMed
description OBJECTIVE: The mechanistic basis for the breakdown of T-cell tolerance in type 1 diabetes is unclear and could result from a gain of effector function and/or loss of regulatory function. In humans, the CD4+CD25+Foxp3+ T–cell compartment contains both effector and regulatory T cells, and it is not known how their relative proportions vary in disease states. RESEARCH DESIGN AND METHODS: We performed a longitudinal study of CD4+CD25+ T–cell function in children with type 1 diabetes at onset and throughout the 1st year of disease. Function was assessed using single-cell assays of proliferation, cytokine production, and suppression. Type 1 diabetic individuals were compared with age-matched control subjects, and suppression was directly assessed by coculture with control T–cell targets. RESULTS: We identify novel functional changes within the type 1 diabetes CD4+CD25+ compartment. Type 1 diabetic CD4+CD25+ cells exhibited a striking increase in proliferative capacity in coculture with CD4 T cells that was present at onset and stable 9–12 months from diagnosis. Elevated type 1 diabetes CD4+CD25+ cell proliferation correlated with increased inflammatory cytokines interleukin 17 and tumor necrosis factor-α but not γ-interferon. Type 1 diabetes CD4+CD25+ cytokine production occurred coincident with suppression of the same cytokines in the control targets. Indeed, enhanced proliferation/cytokines by CD4+CD25+ cells was uncoupled from their suppressive ability. Longitudinally, we observed a transient defect in type 1 diabetes CD4+CD25+ suppression that unexpectedly correlated with measures of improved metabolic function. CONCLUSIONS: Type 1 diabetes onset, and its subsequent remission period, is associated with two independent functional changes within the CD4+CD25+ T–cell compartment: a stable increase in effector function and a transient decrease in regulatory T–cell suppression.
format Online
Article
Text
id pubmed-3142074
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-31420742012-08-01 Uncoupling of Proliferation and Cytokines From Suppression Within the CD4+CD25+Foxp3+ T–Cell Compartment in the 1st Year of Human Type 1 Diabetes Hughson, Angela Bromberg, Irina Johnson, Barbara Quataert, Sally Jospe, Nicholas Fowell, Deborah J. Diabetes Immunology and Transplantation OBJECTIVE: The mechanistic basis for the breakdown of T-cell tolerance in type 1 diabetes is unclear and could result from a gain of effector function and/or loss of regulatory function. In humans, the CD4+CD25+Foxp3+ T–cell compartment contains both effector and regulatory T cells, and it is not known how their relative proportions vary in disease states. RESEARCH DESIGN AND METHODS: We performed a longitudinal study of CD4+CD25+ T–cell function in children with type 1 diabetes at onset and throughout the 1st year of disease. Function was assessed using single-cell assays of proliferation, cytokine production, and suppression. Type 1 diabetic individuals were compared with age-matched control subjects, and suppression was directly assessed by coculture with control T–cell targets. RESULTS: We identify novel functional changes within the type 1 diabetes CD4+CD25+ compartment. Type 1 diabetic CD4+CD25+ cells exhibited a striking increase in proliferative capacity in coculture with CD4 T cells that was present at onset and stable 9–12 months from diagnosis. Elevated type 1 diabetes CD4+CD25+ cell proliferation correlated with increased inflammatory cytokines interleukin 17 and tumor necrosis factor-α but not γ-interferon. Type 1 diabetes CD4+CD25+ cytokine production occurred coincident with suppression of the same cytokines in the control targets. Indeed, enhanced proliferation/cytokines by CD4+CD25+ cells was uncoupled from their suppressive ability. Longitudinally, we observed a transient defect in type 1 diabetes CD4+CD25+ suppression that unexpectedly correlated with measures of improved metabolic function. CONCLUSIONS: Type 1 diabetes onset, and its subsequent remission period, is associated with two independent functional changes within the CD4+CD25+ T–cell compartment: a stable increase in effector function and a transient decrease in regulatory T–cell suppression. American Diabetes Association 2011-08 2011-07-18 /pmc/articles/PMC3142074/ /pubmed/21715555 http://dx.doi.org/10.2337/db10-1661 Text en © 2011 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Immunology and Transplantation
Hughson, Angela
Bromberg, Irina
Johnson, Barbara
Quataert, Sally
Jospe, Nicholas
Fowell, Deborah J.
Uncoupling of Proliferation and Cytokines From Suppression Within the CD4+CD25+Foxp3+ T–Cell Compartment in the 1st Year of Human Type 1 Diabetes
title Uncoupling of Proliferation and Cytokines From Suppression Within the CD4+CD25+Foxp3+ T–Cell Compartment in the 1st Year of Human Type 1 Diabetes
title_full Uncoupling of Proliferation and Cytokines From Suppression Within the CD4+CD25+Foxp3+ T–Cell Compartment in the 1st Year of Human Type 1 Diabetes
title_fullStr Uncoupling of Proliferation and Cytokines From Suppression Within the CD4+CD25+Foxp3+ T–Cell Compartment in the 1st Year of Human Type 1 Diabetes
title_full_unstemmed Uncoupling of Proliferation and Cytokines From Suppression Within the CD4+CD25+Foxp3+ T–Cell Compartment in the 1st Year of Human Type 1 Diabetes
title_short Uncoupling of Proliferation and Cytokines From Suppression Within the CD4+CD25+Foxp3+ T–Cell Compartment in the 1st Year of Human Type 1 Diabetes
title_sort uncoupling of proliferation and cytokines from suppression within the cd4+cd25+foxp3+ t–cell compartment in the 1st year of human type 1 diabetes
topic Immunology and Transplantation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3142074/
https://www.ncbi.nlm.nih.gov/pubmed/21715555
http://dx.doi.org/10.2337/db10-1661
work_keys_str_mv AT hughsonangela uncouplingofproliferationandcytokinesfromsuppressionwithinthecd4cd25foxp3tcellcompartmentinthe1styearofhumantype1diabetes
AT brombergirina uncouplingofproliferationandcytokinesfromsuppressionwithinthecd4cd25foxp3tcellcompartmentinthe1styearofhumantype1diabetes
AT johnsonbarbara uncouplingofproliferationandcytokinesfromsuppressionwithinthecd4cd25foxp3tcellcompartmentinthe1styearofhumantype1diabetes
AT quataertsally uncouplingofproliferationandcytokinesfromsuppressionwithinthecd4cd25foxp3tcellcompartmentinthe1styearofhumantype1diabetes
AT jospenicholas uncouplingofproliferationandcytokinesfromsuppressionwithinthecd4cd25foxp3tcellcompartmentinthe1styearofhumantype1diabetes
AT fowelldeborahj uncouplingofproliferationandcytokinesfromsuppressionwithinthecd4cd25foxp3tcellcompartmentinthe1styearofhumantype1diabetes